Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ZTEK
Zentek Ltd
CAPPED RATING
Zentek Ltd (ZTEK) is rated C- (2.0/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Value (F). The rating has held at C- for 3 weeks.
Quantitative Factor Evaluation • Updated
Overall Rating
2.0
/ 5.0
C-
Value
F
Factor Score
0.3
/ 5.0
Growth
C+
Factor Score
2.5
/ 5.0
Profitability
C
Factor Score
2.2
/ 5.0
Momentum
C+
Factor Score
2.5
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
N/A
EV / EBITDA
-4.3
Rev Growth YoY
N/A
Gross Margin
0.0%
Price Return 3M
N/A
Price Return 12M
N/A
Catalyst Signal
0.00
Market Cap
$62.3M
TTM Revenue
$108.3K
Price / Sales
575.5
ROE
-53.2%
Historical Factor Score Progression
Held C- for 3 weeks
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-01 | F (0.3) | C+ (2.5) | C (2.2) | C+ (2.5) | C+ (2.6) | C- (2.0) |
| 2026-10-25 | F (0.3) | C+ (2.5) | C (2.2) | C+ (2.5) | C+ (2.6) | C- (2.0) |
| 2026-10-18 | F (0.4) | C+ (2.5) | C (2.2) | C+ (2.5) | C+ (2.6) | C- (2.0) |
| 2026-10-11 | F (0.3) | C+ (2.5) | C (2.2) | C+ (2.5) | C+ (2.6) | C- (2.0) |
| 2026-10-04 | C+ (2.5) | C+ (2.5) | C- (2.0) | C+ (2.5) | C (2.4) | C (2.4) |
Page
1
of
3